Home
Categories
EXPLORE
True Crime
Comedy
Sports
Society & Culture
Business
News
History
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/8b/7b/5a/8b7b5a1a-5802-f391-e273-bcbaad1ce8e1/mza_5858251704041903582.jpg/600x600bb.jpg
A Rare Purpose
Jemma Caprioli
7 episodes
1 week ago
In rarity we unite, connect and find our way to purpose.
Show more...
Medicine
Health & Fitness,
Science,
Life Sciences
RSS
All content for A Rare Purpose is the property of Jemma Caprioli and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In rarity we unite, connect and find our way to purpose.
Show more...
Medicine
Health & Fitness,
Science,
Life Sciences
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/8b/7b/5a/8b7b5a1a-5802-f391-e273-bcbaad1ce8e1/mza_5858251704041903582.jpg/600x600bb.jpg
A Cancer Discovery with Professor Parry Guilford: Clinical Trials, Research Funding and a Candid Chat about Hereditary Cancers
A Rare Purpose
58 minutes
1 year ago
A Cancer Discovery with Professor Parry Guilford: Clinical Trials, Research Funding and a Candid Chat about Hereditary Cancers

Professor Parry Guilford is known for successfully in identifying the first known genetic mutations in the CDH1 gene, leading to the description of a new cancer syndrome Hereditary Diffuse Gastric Cancer (HDGC). This discovery has conservatively saved 27,000 people from developing a severe form of stomach cancer. Parry is determined to continue to change the course of HDGC stomach cancer patients outcomes, he is invested in the CDH1 mutation families and feels their trials as if they were his own. We discuss genetic counselling, the age at which we test our children for hereditary cancers, his work on lobular breast cancer, bowel cancer and funding research. 

A Rare Purpose
In rarity we unite, connect and find our way to purpose.